跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SC13
首页
药物
SC13
SC13
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Application of small-molecular inhibitor SC13 targeting to FEN1 and derivative of small-molecular inhibitor SC13 in preparing tumor treatment medicine
CN 106692155 A
申请人: NANJING UNIVERSITY OF TECHNOLOGY
优先权: 2017
CN
阿霉素联合用药物及其应用
CN 110279704 B
申请人: 南京师范大学
优先权: 2019
CN
Fluorescent multi-mode molecular imaging and drug-loaded breast cancer diagnosis and treatment integrated nanoprobe and preparation method and application thereof
CN 112121183 A
申请人: NANJING UNIVERSITY OF TECHNOLOGY
优先权: 2020
CN
Application of FEN1 inhibitor combined with CAR-T cells in preparation of antitumor drugs
CN 117224661 A
申请人: NANJING UNIVERSITY OF TECHNOLOGY
优先权: 2023
CN
Application of FEN1 as target spot in treatment of cervical small cell neuroendocrine cancer
CN 119165165 A
申请人: UNIV SHANXI MEDICAL
优先权: 2024
CN
药物
反馈